MEHCQ (Chrome Holding Co) Research & Development: $97.2 Mil (TTM As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEHCQ Chrome Holding Co MEHCQ
58 GF Score
Price $3.50
View Full Analysis

What is Chrome Holding Co Research & Development?

Chrome Holding Co MEHCQ -2.78% 58 Research & Development is $97.2 Mil as of Jun. 2025. GuruFocus rates MEHCQ with a GF Score™ of 58/100.

Research & Development is the aggregate amount of research and development expenses during the year. Chrome Holding Co's Research & Development for the three months ended in Jun. 2025 was $14.5 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 was $97.2 Mil.

Chrome Holding Co  (OTCPK:MEHCQ) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Chrome Holding Co Research & Development Related Terms

Chrome Holding Co Research & Development Historical Data

* Premium members only.

The historical data trend for Chrome Holding Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chrome Holding Co Research & Development Chart

Chrome Holding Co Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Research & Development
Get a 7-Day Free Trial 159.86 189.38 115.99 105.02 101.59

Chrome Holding Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.04 20.22 21.54 14.45 0.00
MEHCQ
58GF Score
Chrome Holding Co MEHCQ
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chrome Holding Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $97.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $97.2 Mil mean?
Chrome Holding Co (MEHCQ) has a Research & Development of $97.2 Mil as of Jun. 2025. Research and development expense is the total cost for research and development activities. View historical data on Chrome Holding Co and its competitors.
Is Chrome Holding Co's Research & Development too high?
Chrome Holding Co's current Research & Development is $97.2 Mil. Overall, Chrome Holding Co has a GF Score™ of 58/100, reflecting its overall financial health beyond just this single metric.
How does Chrome Holding Co's Research & Development compare to BDSX and XGN?
Chrome Holding Co's Research & Development of $97.2 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Diagnostics & Research company?
A good Research & Development depends on the Medical Diagnostics & Research industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Chrome Holding Co and its competitors. Chrome Holding Co's current Research & Development is $97.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chrome Holding Co stock overvalued right now?
Chrome Holding Co (MEHCQ) has a current Research & Development of $97.2 Mil. The current Research & Development is $97.2 Mil. Chrome Holding Co's overall GF Score™ is 58/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Chrome Holding Co (MEHCQ), the current Research & Development is $97.2 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chrome Holding Co Business Description

Address 870 Market Street, Room 415, South San Francisco, CA, USA, 94102
Chrome Holding Co, formerly known as 23andMe Holding Co, is a consumer-facing healthcare technology company, involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes one main sector that is Consumer and Research Services. The company generates maximum revenue from the Consumer and Research Services segment.
58GF Score

Get the complete analysis for MEHCQ

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.50
Price